Jeil Pharma Holdings Inc completed the acquisition of additional 35.2% stake in Jeil Pharmaceutical Co.,Ltd for approximately KRW 250 billion.
November 15, 2018
Share
Jeil Pharma Holdings Inc (KOSE:A002620) made an offer to acquire an additional 47.6% stake in Jeil Pharmaceutical Co.,Ltd (KOSE:A271980) for approximately KRW 490 billion on October 2, 2018. Jeil Pharma Holdings will acquire additional 7 million shares of Jeil Pharmaceutical Co and will issue 2.2494363 Jeil Pharma Holdings Inc shares for each share of Jeil Pharmaceutical Co.,Lt which equates to an offer per share of KRW 53874. Jeil Pharma Holdings will issue 15.7 million shares of Jeil Pharmaceutical. Board of Jeil Pharma Holdings passed a resolution for the transaction on October 2, 2018. Tender offer period is from October 26, 2018 to November 15, 2018.
Jeil Pharma Holdings Inc (KOSE:A002620) completed the acquisition of additional 35.2% stake in Jeil Pharmaceutical Co.,Ltd (KOSE:A271980) for approximately KRW 250 billion on November 16, 2018. Under the terms of transaction, Jeil Pharma Holdings acquired an additional 5.2 million shares in Jeil Pharmaceutical.
JEIL PHARMACEUTICAL CO.,LTD is a Korea-based company principally engaged in the manufacturing and distribution of pharmaceuticals. The Company provides anti-inflammatory painkillers, anticancer drugs, gastritis drugs, antibiotics, ulcer treatments, antidepressant drugs, pollakisuria and incontinence treatments, impetigo drugs, septicemia treatments, hyperlipidemia treatments, peripheral neuropathic pain drugs, hypertension drugs and others. The Company distributes its products within domestic market and to overseas markets.
JEIL PHARMACEUTICAL CO.,LTD 
